These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

431 related items for PubMed ID: 36510261

  • 1. Impact of disease-modifying therapy on dendritic cells and exploring their immunotherapeutic potential in multiple sclerosis.
    Liu C, Zhu J, Mi Y, Jin T.
    J Neuroinflammation; 2022 Dec 12; 19(1):298. PubMed ID: 36510261
    [Abstract] [Full Text] [Related]

  • 2. Generation, Characteristics and Clinical Trials of Ex Vivo Generated Tolerogenic Dendritic Cells.
    Kim SH, Jung HH, Lee CK.
    Yonsei Med J; 2018 Sep 12; 59(7):807-815. PubMed ID: 30091313
    [Abstract] [Full Text] [Related]

  • 3. Tolerogenic Dendritic Cell-Based Approaches in Autoimmunity.
    Passeri L, Marta F, Bassi V, Gregori S.
    Int J Mol Sci; 2021 Aug 05; 22(16):. PubMed ID: 34445143
    [Abstract] [Full Text] [Related]

  • 4. Tolerogenic Dendritic Cells as a Promising Antigen-Specific Therapy in the Treatment of Multiple Sclerosis and Neuromyelitis Optica From Preclinical to Clinical Trials.
    Flórez-Grau G, Zubizarreta I, Cabezón R, Villoslada P, Benitez-Ribas D.
    Front Immunol; 2018 Aug 05; 9():1169. PubMed ID: 29904379
    [Abstract] [Full Text] [Related]

  • 5. Fulfilling the dream: tolerogenic dendritic cells to treat multiple sclerosis.
    Gross CC, Jonuleit H, Wiendl H.
    Eur J Immunol; 2012 Mar 05; 42(3):569-72. PubMed ID: 22488360
    [Abstract] [Full Text] [Related]

  • 6. Tolerogenic Immunotherapy: Targeting DC Surface Receptors to Induce Antigen-Specific Tolerance.
    Castenmiller C, Keumatio-Doungtsop BC, van Ree R, de Jong EC, van Kooyk Y.
    Front Immunol; 2021 Mar 05; 12():643240. PubMed ID: 33679806
    [Abstract] [Full Text] [Related]

  • 7. Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases.
    Mackern-Oberti JP, Llanos C, Vega F, Salazar-Onfray F, Riedel CA, Bueno SM, Kalergis AM.
    Autoimmun Rev; 2015 Feb 05; 14(2):127-39. PubMed ID: 25449681
    [Abstract] [Full Text] [Related]

  • 8. Tolerogenic dendritic cell vaccines to treat autoimmune diseases: can the unattainable dream turn into reality?
    Van Brussel I, Lee WP, Rombouts M, Nuyts AH, Heylen M, De Winter BY, Cools N, Schrijvers DM.
    Autoimmun Rev; 2014 Feb 05; 13(2):138-50. PubMed ID: 24120737
    [Abstract] [Full Text] [Related]

  • 9. Development and Functional Characterization of Murine Tolerogenic Dendritic Cells.
    Wei HJ, Letterio JJ, Pareek TK.
    J Vis Exp; 2018 May 18; (135):. PubMed ID: 29863666
    [Abstract] [Full Text] [Related]

  • 10. High-throughput screening identification of novel immunomodulatory combinations for the generation of tolerogenic dendritic cells.
    Jia S, Kim J, Esser-Kahn AP, Deak P.
    Front Med (Lausanne); 2023 May 18; 10():1298424. PubMed ID: 38249971
    [Abstract] [Full Text] [Related]

  • 11. Regulatory dendritic cells in autoimmunity: A comprehensive review.
    Liu J, Cao X.
    J Autoimmun; 2015 Sep 18; 63():1-12. PubMed ID: 26255250
    [Abstract] [Full Text] [Related]

  • 12. Role of the immunogenic and tolerogenic subsets of dendritic cells in multiple sclerosis.
    Xie ZX, Zhang HL, Wu XJ, Zhu J, Ma DH, Jin T.
    Mediators Inflamm; 2015 Sep 18; 2015():513295. PubMed ID: 25705093
    [Abstract] [Full Text] [Related]

  • 13. Tolerogenic Dendritic Cells Generated with Tofacitinib Ameliorate Experimental Autoimmune Encephalomyelitis through Modulation of Th17/Treg Balance.
    Zhou Y, Leng X, Luo S, Su Z, Luo X, Guo H, Mo C, Zou Q, Liu Y, Wang Y.
    J Immunol Res; 2016 Sep 18; 2016():5021537. PubMed ID: 28070525
    [Abstract] [Full Text] [Related]

  • 14. Antigen Loading (e.g., Glutamic Acid Decarboxylase 65) of Tolerogenic DCs (tolDCs) Reduces Their Capacity to Prevent Diabetes in the Non-Obese Diabetes (NOD)-Severe Combined Immunodeficiency Model of Adoptive Cotransfer of Diabetes As Well As in NOD Mice.
    Funda DP, Goliáš J, Hudcovic T, Kozáková H, Špíšek R, Palová-Jelínková L.
    Front Immunol; 2018 Sep 18; 9():290. PubMed ID: 29503651
    [Abstract] [Full Text] [Related]

  • 15. Tolerogenic dendritic cells for reprogramming of lymphocyte responses in autoimmune diseases.
    García-González P, Ubilla-Olguín G, Catalán D, Schinnerling K, Aguillón JC.
    Autoimmun Rev; 2016 Nov 18; 15(11):1071-1080. PubMed ID: 27485011
    [Abstract] [Full Text] [Related]

  • 16. Glyburide-treated human monocyte-derived dendritic cells loaded with insulin represent tolerogenic features with anti-inflammatory responses and modulate autologous T cell responses in vitro.
    Alipour S, Kazemi T, Sadeghi MR, Heris JA, Masoumi J, Naseri B, Baghbani E, Sohrabi S, Baradaran B.
    Int Immunopharmacol; 2024 Jan 05; 126():111230. PubMed ID: 37979448
    [Abstract] [Full Text] [Related]

  • 17. Tolerogenic dendritic cell-based treatment for multiple sclerosis (MS): a harmonised study protocol for two phase I clinical trials comparing intradermal and intranodal cell administration.
    Willekens B, Presas-Rodríguez S, Mansilla MJ, Derdelinckx J, Lee WP, Nijs G, De Laere M, Wens I, Cras P, Parizel P, Van Hecke W, Ribbens A, Billiet T, Adams G, Couttenye MM, Navarro-Barriuso J, Teniente-Serra A, Quirant-Sánchez B, Lopez-Diaz de Cerio A, Inogés S, Prosper F, Kip A, Verheij H, Gross CC, Wiendl H, Van Ham MS, Ten Brinke A, Barriocanal AM, Massuet-Vilamajó A, Hens N, Berneman Z, Martínez-Cáceres E, Cools N, Ramo-Tello C, RESTORE consortium.
    BMJ Open; 2019 Sep 09; 9(9):e030309. PubMed ID: 31501122
    [Abstract] [Full Text] [Related]

  • 18. Clinical and immunological control of experimental autoimmune encephalomyelitis by tolerogenic dendritic cells loaded with MOG-encoding mRNA.
    Derdelinckx J, Mansilla MJ, De Laere M, Lee WP, Navarro-Barriuso J, Wens I, Nkansah I, Daans J, De Reu H, Jolanta Keliris A, Van Audekerke J, Vanreusel V, Pieters Z, Van der Linden A, Verhoye M, Molenberghs G, Hens N, Goossens H, Willekens B, Cras P, Ponsaerts P, Berneman ZN, Martínez-Cáceres EM, Cools N.
    J Neuroinflammation; 2019 Aug 15; 16(1):167. PubMed ID: 31416452
    [Abstract] [Full Text] [Related]

  • 19. Tolerogenic dendritic cells and rheumatoid arthritis: current status and perspectives.
    Zhao Y, Zhang A, Du H, Guo S, Ning B, Yang S.
    Rheumatol Int; 2012 Apr 15; 32(4):837-44. PubMed ID: 21904923
    [Abstract] [Full Text] [Related]

  • 20. Vaccination with autologous dendritic cells: from experimental autoimmune encephalomyelitis to multiple sclerosis.
    Link H, Huang YM, Masterman T, Xiao BG.
    J Neuroimmunol; 2001 Mar 01; 114(1-2):1-7. PubMed ID: 11240009
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.